ATE245443T1 - Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer - Google Patents

Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer

Info

Publication number
ATE245443T1
ATE245443T1 AT97951010T AT97951010T ATE245443T1 AT E245443 T1 ATE245443 T1 AT E245443T1 AT 97951010 T AT97951010 T AT 97951010T AT 97951010 T AT97951010 T AT 97951010T AT E245443 T1 ATE245443 T1 AT E245443T1
Authority
AT
Austria
Prior art keywords
fibronectin
buffer
concentrated solutions
promoters
producing concentrated
Prior art date
Application number
AT97951010T
Other languages
English (en)
Inventor
Andre Beaulieu
Robert Paquin
Original Assignee
Andre Beaulieu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Beaulieu filed Critical Andre Beaulieu
Application granted granted Critical
Publication of ATE245443T1 publication Critical patent/ATE245443T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97951010T 1996-12-17 1997-12-12 Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer ATE245443T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/767,868 US5821220A (en) 1995-06-07 1996-12-17 Method of producing concentrated non-buffered solutions of fibronectin
PCT/CA1997/000966 WO1998026797A1 (en) 1996-12-17 1997-12-12 Wound healing formulations containing human plasma fibronectin

Publications (1)

Publication Number Publication Date
ATE245443T1 true ATE245443T1 (de) 2003-08-15

Family

ID=25080820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97951010T ATE245443T1 (de) 1996-12-17 1997-12-12 Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer

Country Status (11)

Country Link
US (1) US5821220A (de)
EP (1) EP0951294B1 (de)
JP (1) JP2001510463A (de)
AT (1) ATE245443T1 (de)
AU (1) AU747209B2 (de)
CA (1) CA2275193A1 (de)
DE (1) DE69723725T2 (de)
DK (1) DK0951294T3 (de)
ES (1) ES2203827T3 (de)
PT (1) PT951294E (de)
WO (1) WO1998026797A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US20030105007A1 (en) * 1995-06-07 2003-06-05 Andre Beaulieu PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
CA2326438A1 (en) * 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
DE10242320A1 (de) * 2002-09-12 2004-03-25 Thomas Steinmetz Golfspielanlage
GB0327046D0 (en) * 2003-11-20 2003-12-24 Queen Mary & Westfield College Regulation of sperm function
AU2012279001A1 (en) 2011-07-05 2014-01-23 The Research Foundation For The State University Of New York Compositions and methods for spinal disc repair and other surgical and non-surgical indications
AU2016314611C1 (en) 2015-09-04 2019-12-19 Remedor Biomed Ltd. Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
CN109568652A (zh) * 2018-12-26 2019-04-05 粤肽生物科技(珠海)有限公司 促进伤口快速愈合的敷料组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) * 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin

Also Published As

Publication number Publication date
ES2203827T3 (es) 2004-04-16
AU747209B2 (en) 2002-05-09
CA2275193A1 (en) 1998-06-25
DE69723725T2 (de) 2004-04-22
JP2001510463A (ja) 2001-07-31
US5821220A (en) 1998-10-13
DK0951294T3 (da) 2003-11-17
EP0951294B1 (de) 2003-07-23
EP0951294A1 (de) 1999-10-27
AU5470998A (en) 1998-07-15
DE69723725D1 (de) 2003-08-28
WO1998026797A1 (en) 1998-06-25
PT951294E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
IT1179359B (it) Composizione per rigenerare il collageno del tessuto connettivo della pelle, e suo procedimento di preparazione
IT1273742B (it) Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
AU6777196A (en) Method of promoting angiogenesis
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
ATE245443T1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
NO162894C (no) Fremgangsmaate til fremstilling av en kompress inneholdende middel for aa rense saar og stimulere til leging.
DE69820254D1 (de) Dermales hüllgewebe in der wundheilung
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO934317D0 (no) Anvendelse av visse metanbisfosfonsyrederivater i brudd-heling
BR9002240A (pt) Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
GB2368523A (en) Solid wound healing formulations containing fibronectin
UA18225A (uk) Спосіб лікуваhhя раh
UA42335A (uk) Спосіб лікування гнійних ран
GEP19971090B (en) Plaster “Fagodermi“
NO904611L (no) Farmasoeytiske preparater inneholdende deoksyribonukleosider for saarheling.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951294

Country of ref document: EP

REN Ceased due to non-payment of the annual fee